Genitourinary Cancer,Prostate Cancer Nivolumab + Rucaparib for Treating Patients With mCRPC May 02, 2023
Genitourinary Cancer,Prostate Cancer Improving Outcomes in mCRPC: Cabozantinib and Atezolizumab Combination Therapy May 02, 2023
Genitourinary Cancer,Prostate Cancer Exploring the Efficacy of 177Lu-PSMA-617 in Metastatic Castrate-Resistant Prostate Cancer May 02, 2023
Genitourinary Cancer,Prostate Cancer Rezvilutamide vs Bicalutamide + ADT for Hormone Sensitive Prostate Cancer May 02, 2023
Head & Neck Cancer A New Treatment Option for Recurrent or Metastatic Nasopharyngeal Cancer: Tislelizumab and Chemotherapy May 02, 2023
Head & Neck Cancer Revolutionizing Head and Neck Cancer Treatment: Keynote-048 Trial of Pembrolizumab May 02, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) AEGEAN Trial: Durvalumab Combined With Chemotherapy for Resectable NSCLC May 02, 2023
Esophageal Cancer,Gastrointestinal Cancer Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced Esophageal Cancer May 02, 2023
